State-Based Universal Health Care Act of 2025
Summary
HR4406 is in very early legislative stages—referred to five committees with 34 cosponsors. No funding is authorized. The bill is not a near-term market factor for any healthcare company.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR4406 is an early-stage, unfunded authorization bill with no near-term market impact.
- 2.No specific company revenue is affected by this bill in its current form.
- 3.Market data shows health insurer stocks rallying despite the bill's existence, confirming it is not a threat.
Market Implications
No actionable market implications for specific tickers. The bill is procedural noise at this stage. Investors should monitor committee hearings or markups for signs of momentum, but none exist today.
Full Analysis
The State-Based Universal Health Care Act of 2025 (HR4406) was introduced on July 15, 2025, and referred to five committees. It has 34 cosponsors, all Democrats. The bill text creates a waiver framework for states to establish universal health care systems, but authorizes no specific funding. No hearings, markups, or votes have occurred. The legislative path is long and uncertain. Major health insurers (UNH, CI, HUM, CVS) have rallied 8-41% in the last 30 days, confirming the market sees no threat from this bill. For-profit hospital operators (HCA, UHS) declined 8-12% in the same period, but this divergence is driven by non-legislative factors. No tickers warrant inclusion because no causal chain can be constructed from this early-stage, unfunded authorization bill to any specific company's revenue. The sponsor (Rep. Khanna, D-CA) is a senior progressive but not a committee chair. The companion bill S2286 is also in early stages. No market-moving action is expected in the current Congress.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Executive Order: Promoting Efficiency, Accountability, and Performance in Federal Contracting
Executive Order: Accelerating Medical Treatments for Serious Mental Illness
ADVANCED TECHNOLOGY INTERNATIONAL: $304M Department of Health and Human Services Contract
Protecting Health Care and Lowering Costs Act of 2025
Executive Order: Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
Veterans SPORT Act
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $1.1B Department of Veterans Affairs Contract
Consolidated Appropriations Act, 2026
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.